ASP Isotopes Inc. Common Stock

NASDAQ ASPI

Data sourced from iex and EODHD
Download Data

ASP Isotopes Inc. Common Stock Stock-Based Compensation 2 year CAGR for the Trailing 12 Months (TTM) ending March 31, 2024: 2,472.44%

ASP Isotopes Inc. Common Stock Stock-Based Compensation 2 year CAGR is 2,472.44% for the Trailing 12 Months (TTM) ending March 31, 2024. Stock-Based Compensation represents the cost of employee compensation provided in the form of equity-based instruments, such as stock options or restricted stock units. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • ASP Isotopes Inc. Common Stock Stock-Based Compensation for the Trailing 12 Months (TTM) ending December 31, 2022 was USD 2.00 M, a 15,015.39% change year over year.
  • ASP Isotopes Inc. Common Stock Stock-Based Compensation for the Trailing 12 Months (TTM) ending December 31, 2021 was USD 13.23 K.
NASDAQ: ASPI

ASP Isotopes Inc. Common Stock

CEO Mr. Paul Elliot Mann
IPO Date Nov. 10, 2022
Location United States
Headquarters 433 Plaza Real, Boca Raton, FL, United States, 33432
Employees 76
Sector Basic Materials
Industry Chemicals
Description

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

StockViz Staff

September 20, 2024

Any question? Send us an email